ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Obama’s First Budget Proposes $6 Billion For Cancer Research As Step To Doubling

February 27, 2009

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

In Brief: Pardee, Durant Head AASR, ASCO; Sartorell, Hellman Presidents Elect; ONS Reelects Johnson

May 31, 1985

In Brief: Long Island In, Seattle Out Of Community Based Cancer Program; Six Still In Running

December 10, 1976

Studies Started On Use Of Heroin, THC for Pain, Discomfort Therapy

October 13, 1978

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014